Home›Articles›A cell therapy for children whose graft versus host disease resisted steroidsArticleA cell therapy for children whose graft versus host disease resisted steroidsArticlesConnectionsSourcesComments (0)Reader Challenges (0)ConnectionsArticle OnRemestemcel, Drugs and Medicinal Substances Well-attested SourcesFirst-in-class Cell Therapy for Steroid-refractory Graft Versus Host Disease (AACR)Body, clinical trial paragraphQuote, Body, clinical trial paragraphThe decision was based on results from the multicenter, prospective, single-arm, phase III MSB-GVHD001 clinical trial.View the SourceMedicine Atlas Original Articlestier 1Comments (0)No comments yet. Be the first to share a thought.Sign in to join the discussion.Reader Challenges (0)No disputes yet. Spotted an error or a better source? Open the first one.Sign in to dispute this or suggest a correction.